title: Effect of different concentrations of amino acids in human serum and follicular fluid on the development of one-cell mouse embryos in vitro.
abstract: As a model for establishing an optimized medium for human in vitro fertilization (IVF), modified human tubal fluid (HTF) media containing amino acids at concentrations found in human serum and follicular fluid were prepared, and the effect of the media on development of random-bred (ICR) and F1 hybrid (CBF1) mice embryos was studied. The total concentrations of amino acids found in serum and follicular fluid were about one-third to one-half the concentrations present in two conventional media used in human IVF: Ham's F-10 and Eagle's minimal essential medium (MEM). When ICR mouse embryos were cultured in the HTF medium containing 21 amino acids at concentrations found in follicular fluid, the number of embryos developing to morulae at 72 h and to blastocysts at 96 h increased in comparison with those cultured in HTF medium. When HTF containing amino acids at concentrations found in serum was used, only induced morula formation at 72 h was enhanced. The number of hatching blastocysts at 96 h also increased when CBF1 mouse embryos were cultured with HTF supplemented with amino acids at concentrations found in follicular fluid. When ICR mouse embryos were cultured in modified HTF media containing concentrations of amino acids found in Ham's F-10 and MEM that contained higher concentrations of glutamine, embryo development was inhibited. The amount of ammonium produced during incubation for 3 days was significantly less when embryos were cultured in media containing concentrations of amino acids found in follicular fluid compared with when Ham's F-10 or MEM was the culture medium. Ammonium is produced by the breakdown of glutamine in the culture medium during incubation with or without embryos. These results suggest that the concentrations of amino acids found in follicular fluid are more effective and safer for embryo culture than those in other media currently in use.
authors.affiliation: Research and Development Center, Fuso Pharmaceutical Industries Ltd, Osaka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nakazawa
authors.forename: K
authors.initials: K
authors.lastname: Ohashi
authors.forename: M
authors.initials: M
authors.lastname: Yamada
authors.forename: S
authors.initials: S
authors.lastname: Shinoda
authors.forename: F
authors.initials: F
authors.lastname: Saji
authors.forename: Y
authors.initials: Y
authors.lastname: Murata
authors.forename: H
authors.initials: H
authors.lastname: Araki
mesh_terms: D000596:Amino Acids / Q000097:blood / Q000502:physiology*; D000818:Animals; D001755:Blastocyst / Q000502:physiology*; D002478:Cells, Cultured; D003470:Culture Media; D005314:Embryonic and Fetal Development; D005260:Female; D015571:Follicular Fluid / Q000378:metabolism*; D006801:Humans; D006824:Hybridization, Genetic; D051379:Mice; D008813:Mice, Inbred ICR; D018709:Statistics, Nonparametric
chemical_list: D000596:Amino Acids; D003470:Culture Media